HUP0004627A2 - Farnezil-protein transzferáz inhibitor hatású új triciklusos szulfonamidszármazékok és a vegyületeket tartalmazó gyógyszerkészítmények - Google Patents

Farnezil-protein transzferáz inhibitor hatású új triciklusos szulfonamidszármazékok és a vegyületeket tartalmazó gyógyszerkészítmények

Info

Publication number
HUP0004627A2
HUP0004627A2 HU0004627A HUP0004627A HUP0004627A2 HU P0004627 A2 HUP0004627 A2 HU P0004627A2 HU 0004627 A HU0004627 A HU 0004627A HU P0004627 A HUP0004627 A HU P0004627A HU P0004627 A2 HUP0004627 A2 HU P0004627A2
Authority
HU
Hungary
Prior art keywords
alkyl
heteroaryl
cycloalkyl
group
compounds
Prior art date
Application number
HU0004627A
Other languages
English (en)
Hungarian (hu)
Inventor
Ronald J. Doll
Viyyoor M. Girijavallabhan
F. George Njoroge
Arthur G. Taveras
Bancha Vibulbhan
Original Assignee
Schering Corp.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp. filed Critical Schering Corp.
Publication of HUP0004627A2 publication Critical patent/HUP0004627A2/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04Ortho- or peri-condensed ring systems
    • C07D221/06Ring systems of three rings
    • C07D221/16Ring systems of three rings containing carbocyclic rings other than six-membered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
HU0004627A 1997-06-17 1998-06-15 Farnezil-protein transzferáz inhibitor hatású új triciklusos szulfonamidszármazékok és a vegyületeket tartalmazó gyógyszerkészítmények HUP0004627A2 (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US87705097A 1997-06-17 1997-06-17
PCT/US1998/011508 WO1998057949A1 (en) 1997-06-17 1998-06-15 Novel tricyclic sulfonamide inhibitors of farnesyl-protein transferase

Publications (1)

Publication Number Publication Date
HUP0004627A2 true HUP0004627A2 (hu) 2001-10-28

Family

ID=25369146

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0004627A HUP0004627A2 (hu) 1997-06-17 1998-06-15 Farnezil-protein transzferáz inhibitor hatású új triciklusos szulfonamidszármazékok és a vegyületeket tartalmazó gyógyszerkészítmények

Country Status (14)

Country Link
EP (1) EP0989980A1 (zh)
JP (1) JP2002507192A (zh)
KR (1) KR20010013826A (zh)
CN (1) CN1267290A (zh)
AR (1) AR012989A1 (zh)
AU (1) AU8253698A (zh)
CA (1) CA2293358C (zh)
CO (1) CO4940475A1 (zh)
HU (1) HUP0004627A2 (zh)
IL (1) IL133393A0 (zh)
NZ (1) NZ501619A (zh)
PE (1) PE86199A1 (zh)
WO (1) WO1998057949A1 (zh)
ZA (1) ZA985218B (zh)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6689789B2 (en) 1997-06-17 2004-02-10 Schering Corporation Compounds useful for inhibition of farnesyl protein transferase
US7517884B2 (en) 1998-03-30 2009-04-14 Kalypsys Inc. Sulfonyl-substituted bicyclic compounds as modulators of PPAR
US7494999B2 (en) 2004-10-29 2009-02-24 Kalypsys, Inc Sulfonyl-substituted bicyclic compounds as modulators of PPAR
US7342016B2 (en) 2000-08-30 2008-03-11 Schering Corporation Farnesyl protein transferase inhibitors as antitumor agents
PE20020635A1 (es) * 2000-11-29 2002-07-11 Schering Corp Compuestos triciclicos como inhibidores de la farnesil transferasa
NZ566831A (en) 2005-10-25 2011-09-30 Kalypsys Inc Salts of modulators of PPAR and methods of treating metabolic disorders
WO2008091863A1 (en) 2007-01-23 2008-07-31 Kalypsys, Inc. Sulfonyl-substituted bicyclic compounds as ppar modulators for the treatment of non-alcoholic steatohepatitis
US9796717B2 (en) * 2013-02-19 2017-10-24 Icahn School Of Medicine At Mount Sinai Tricyclic heterocycles as anticancer agents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2164717T3 (es) * 1993-10-15 2002-03-01 Schering Corp Compuestos triciclicos de sulfonamida utiles para inhibir la funcion de la proteina-g y para el tratamiento de enfermedades proliferativas.
IL117798A (en) * 1995-04-07 2001-11-25 Schering Plough Corp Tricyclic compounds useful for inhibiting the function of protein - G and for the treatment of malignant diseases, and pharmaceutical preparations containing them
IL117797A0 (en) * 1995-04-07 1996-08-04 Pharmacopeia Inc Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases

Also Published As

Publication number Publication date
CO4940475A1 (es) 2000-07-24
PE86199A1 (es) 1999-09-24
EP0989980A1 (en) 2000-04-05
CA2293358C (en) 2008-08-05
ZA985218B (en) 1998-12-15
IL133393A0 (en) 2001-04-30
CA2293358A1 (en) 1998-12-23
KR20010013826A (ko) 2001-02-26
NZ501619A (en) 2002-02-01
JP2002507192A (ja) 2002-03-05
WO1998057949A1 (en) 1998-12-23
CN1267290A (zh) 2000-09-20
AU8253698A (en) 1999-01-04
AR012989A1 (es) 2000-11-22

Similar Documents

Publication Publication Date Title
HUP0002954A2 (hu) Farnezil-protein transzferáz új N-szubsztituált-karbamid inhibitorai
HUP0000121A2 (hu) Farnezil-protein transzferáz triciklusos inhibitorai, e vegyületeket tartalmazó gyógyszerkészítmények és alkalmazásuk
EP1206935A4 (en) TH2 DIFFERENTIAL INHIBITION
HUP0004627A2 (hu) Farnezil-protein transzferáz inhibitor hatású új triciklusos szulfonamidszármazékok és a vegyületeket tartalmazó gyógyszerkészítmények
AP9801274A0 (en) Lactone derivatives of 17, beta.carboxy, carbothio and amide androstane derivatives.
HUP0001109A2 (hu) Triciklusos farnezil-protein transzferáz inhibitorok mint tumorellenes vegyületek
UA41342C2 (uk) 2,3,4,5-тетрагідро-1,4-бензотіазепіни, їх стереоізомери або їх фармацевтично прийнятні солі, спосіб їх одержання та фармацевтична композиція на їх основі
ES2110620T3 (es) Derivados de la 4-aza-5-alfa-androstan-3-ona sustituidos en la posicion 17-beta.
NZ313185A (en) 2-(4-substituted)-benzylamino-2-methyl-propanamide derivatives
AP9801321A0 (en) 2-(4-aryl or heteroaryl-piperazin-1-ylmethyl)-h-indole derivatives.
ID954B (id) STEROID 3-KARBOKSI TERSUBSTITUSI-17β TAK JENUH
AU767923C (en) Novel 2-(N-cyanoimino)thiazolidin-4-one derivatives
NO913176L (no) Morfolinylderivater av doxorubicin og deres fremstilling.
HUP0004588A2 (hu) Szubsztituált 1,2,3,4,5,6-hexahidro-2,6-metano-3-benzazocin-10-ol-származékok, eljárás előállításukra és alkalmazásuk gyógyszerként, valamint a vegyületeket tartalmazó gyógyszerkészítmények
ATE46159T1 (de) Pyridazinone, inotrope mittel.
BG102129A (en) Triazoline and isosazoline derivatives of bis-oxime and their application as persticides
NO881759L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzo- og tieno- 3,4-dihydro- pyridinderivater.
EP0878196A4 (en) INHIBITORS OF KAINIC ACID NEUROTOXICITY AND PYRIDOTHIAZINE DERIVATIVES
EP0721945A4 (en) BENZOLACTAM DERIVATIVES
ES2003100A6 (es) Un procedimiento para preparar imidazoles
DE3675524D1 (de) Dem antibiotikum tan-749 aehnliche verbindungen und ihre herstellung.
AU597923B2 (en) 5-aminoalkyl-beta-carboline derivatives, their production and their use as drugs
IS7100A (is) Notkun á þíasólafleiðum til framleiðslu á lyfi til að vernda hvatbera
AU6676098A (en) Substituted tetrahydropyrimidine derivatives and their use as polymerization inhibitors for vinyl aromatic compounds
HUP0204149A2 (hu) Új szulfoniloxazolamin-származékok, ezeket tartalmazó gyógyszerkészítmények és eljárás a vegyületek előállítására